LexDanaLexDanabeta
Inventor

Isa Odidi

Inventor
Toronto, CA

Overview

31→
Patents
2001–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 31 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes66%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
10,960,077Abuse and alcohol resistant drug composition202110,653,776Compositions and methods for reducing overdose202010,632,205Pharmaceutical composition having reduced abuse potential202010,624,858Controlled release composition using transition coating, and method of preparing same202010,561,602Controlled extended release pregabalin202010,314,787Controlled release delivery device comprising an organosol coat201910,293,046Compositions and methods for reducing overdose201910,159,649Controlled release delivery device comprising an organosol coat201810,064,828Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems20189,801,939'Compositions and methods for reducing overdose'20179,700,516'Compositions and methods for reducing overdose'20179,700,515'Compositions and methods for reducing overdose'20179,636,306'Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient'20179,561,188'Controlled release delivery device comprising an organosol coat'20179,522,119'Compositions and methods for reducing overdose'20169,078,827'Pharmaceutical composition having reduced abuse potential'20158,802,139'Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient'20148,603,520'Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors'20138,394,409'Controlled extended drug release technology'20137,906,143'Controlled release pharmaceutical delivery device and process for preparation thereof'20117,858,119'Extended release pharmaceuticals'20107,090,867'Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum'20066,893,661'Controlled release formulations using intelligent polymers'20056,800,668'Syntactic deformable foam compositions and methods for making'20046,676,966'Extended release metformin hydrochloride formulations'20046,652,882'Controlled release formulation containing bupropion'20036,607,751'Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum'20036,509,037'Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof'20036,479,075'Pharmaceutical formulations for acid labile substances'20026,312,724'Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof'20016,296,876'Pharmaceutical formulations for acid labile substances'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2011Based in Mississauga, CA· patent location history
2003–2021Patents assigned to INTELLIPHARMACEUTICS CORP (17)· patent assignee history
2003Patents assigned to INTELLIPHARAMACEUTICS CORP (1)· patent assignee history
2004–2021Based in Toronto, CA· patent location history
2004–2017Based in Ontario, CA· patent location history
2005Patents assigned to BIOVAIL CORP (1)· patent assignee history
2010–2021Patents assigned to ODIDI ISA (17)· patent assignee history
2010–2021Patents assigned to ODIDI AMINA (10)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTELLIPHARMACEUTICS CORP172003–2021
ODIDI ISAself172010–2021
ODIDI AMINA102010–2021
BIOVAIL CORP12005
INTELLIPHARAMACEUTICS CORP12003
Locations
LocationPatentsSpan
Toronto, CA212004–2021
Mississauga, CA72001–2011
Ontario, CA32004–2017